Key stats
About IQVIA Holdings, Inc.
Sector
Industry
CEO
Ari Bousbib
Website
Headquarters
Durham
Founded
1950
ISIN
BRI1QVBDR007
FIGI
BBG00RD73CK8
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
$IQV with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $IQV after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 57.14%.
IQV - H&S Continuation Pattern H&S patterns can be seen to form and lead to new highs once finished forming
Two have been seen so far, and the left shoulder has formed on the third so far
This third will form and lead to new highs
$IQV with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $IQV after a Positive over reaction following its earnings release placing the stock in drift B.
IQVIA bearishIQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. IQVIA is the largest Healthcare Data Science Company and leader in Human Data Science Technology
set sl above the curve
IQVA - Short target = recent lowsIQVA has a nice short setup. I would say it's recent lows are a high probability, and maybe it could go a little lower to its 200ma. I can imagine a possible scenario is that it might try to find support on it's Monthly chart at the 8ema (as it did two months ago).
Just posting for fun - may not
IQV ready to move higher!* Excellent earnings year over year
* Strong up trend since inception
* Consolidated for about a month before breaking resistance in August and using it as support
* Consolidated for about another month continuing to use $254 as support
* Looking to move higher as volume is coming in and testing $25
Clear skies above ATHVery interesting company, great for a long portfolio, advanced analytics applied to life sciences research. Earnings 10/20.Looks good if it can break through to ATH. Note: Illiquid options with a wide bid/ask. Unusually high open interest on Dec 18 2020 170C.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
